Literature DB >> 17967335

Brain natriuretic peptide increases in septic patients without severe sepsis or shock.

Nikolaos I Nikolaou1, Constantin Goritsas, Maria Dede, Nikolaos P Paissios, Michalis Papavasileiou, Amalia T Rombola, Angeliki Ferti.   

Abstract

BACKGROUND: B-type natriuretic peptide (BNP) production increases in critically ill septic patients. We assessed the hypothesis that BNP is elevated in patients with community-acquired infections without severe sepsis or septic shock.
METHODS: We studied 54 patients [20 males, median age 39 (interquartile range 23, 71)] without heart disease, persistent arrhythmias, or renal failure. BNP was measured in all patients at hospital admission and at pre-discharge and in a control group of 52 individuals. Myoglobin levels were also measured in septic patients.
RESULTS: The infection was microbial in 40 patients, viral in 11, and of undefined etiology in 3. A systemic inflammatory response was evident in 38 patients on the initial evaluation. BNP on admission was higher in patients than in controls [25 (10, 82) pg/ml vs. 13 (5, 30) pg/ml, p=0.01] and it decreased to 16 (5, 47) pg/ml pre-discharge (p=0.0002). Multiple logistic regression identified the presence of microbial infection as the only independent predictor of an elevated BNP value on admission [adjusted odds ratio 9.8 (1.02-93.8), p=0.04]. In patients with microbial infection, location of infection in the lower respiratory tract and the presence of diabetes mellitus were independent predictors of the magnitude of BNP increase. Myoglobin was also increased on hospital admission 80 (37, 231) ng/ml and decreased pre-discharge to 59 (38, 94) ng/ml, p=0.004. Myoglobin level changes from admission to discharge were more prominent with increasing age and in females.
CONCLUSION: BNP levels are elevated in the acute phase of community-acquired microbial infections without severe sepsis or septic shock.

Entities:  

Year:  2007        PMID: 17967335     DOI: 10.1016/j.ejim.2007.01.006

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  10 in total

Review 1.  Interpretation and use of natriuretic peptides in non-congestive heart failure settings.

Authors:  Shih-Hung Tsai; Yen-Yue Lin; Shi-Jye Chu; Ching-Wang Hsu; Shu-Meng Cheng
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

2.  B-type natriuretic peptide and N-terminal pro-BNP in the acute phase of Kawasaki disease.

Authors:  Satoru Iwashima; Takamichi Ishikawa
Journal:  World J Pediatr       Date:  2013-01-18       Impact factor: 2.764

3.  N-terminal pro-B-type natriuretic peptide for predicting fluid challenge in patients with septic shock.

Authors:  Hui-Bin Huang; Biao Xu; Guang-Yun Liu; Bin Du
Journal:  Ann Transl Med       Date:  2019-06

4.  N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients.

Authors:  Daniel A Duprez; Jacqueline Neuhaus; Russell Tracy; Lewis H Kuller; Steven G Deeks; Chloe Orkin; Albrecht Stoehr; Ian J Woolley; James D Neaton
Journal:  AIDS       Date:  2011-03-13       Impact factor: 4.177

5.  Failed weaning from mechanical ventilation and cardiac dysfunction.

Authors:  Jahan Porhomayon; Peter Papadakos; Nader D Nader
Journal:  Crit Care Res Pract       Date:  2012-09-06

6.  The relationship between body mass index and N-terminal pro-B-type natriuretic peptide in community-acquired pneumonia.

Authors:  Jong Seok Lee; Seok Hoon Ko; Jungyoup Lee; Ki Young Jeong
Journal:  Eur J Clin Nutr       Date:  2020-12-14       Impact factor: 4.884

7.  Myocardial and haemodynamic responses to two fluid regimens in African children with severe malnutrition and hypovolaemic shock (AFRIM study).

Authors:  Nchafatso Obonyo; Bernadette Brent; Peter Olupot-Olupot; Michael Boele van Hensbroek; Irene Kuipers; Sidney Wong; Kenji Shiino; Jonathan Chan; John Fraser; Job B M van Woensel; Kathryn Maitland
Journal:  Crit Care       Date:  2017-05-03       Impact factor: 9.097

8.  Gastroenteritis aggressive versus slow treatment for rehydration (GASTRO): a phase II rehydration trial for severe dehydration: WHO plan C versus slow rehydration.

Authors:  Kirsty A Houston; Jack Gibb; Peter Olupot-Olupot; Nchafatso Obonyo; Ayub Mpoya; Margaret Nakuya; Rita Muhindo; Sophie Uyoga; Jennifer A Evans; Roisin Connon; Diana M Gibb; Elizabeth C George; Kathryn Maitland
Journal:  BMC Med       Date:  2019-07-01       Impact factor: 8.775

9.  Brain natriuretic peptide levels have diagnostic and prognostic capability for cardio-renal syndrome type 4 in intensive care unit patients.

Authors:  Sunghoon Park; Goo-Yeong Cho; Sung Gyun Kim; Yong Il Hwang; Hye-Ryun Kang; Seung Hun Jang; Dong-Gyu Kim; Young Rim Song; Young-A Bae; Ki-Suck Jung
Journal:  Crit Care       Date:  2009-05-15       Impact factor: 9.097

10.  Brain natriuretic Peptide production and secretion in inflammation.

Authors:  Tsuneo Ogawa; Adolfo J de Bold
Journal:  J Transplant       Date:  2012-11-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.